相似文献
1
Cardiotoxicity of commercial 5-fluorouracil vials stems from the alkaline hydrolysis of this drug.
Br J Cancer. 1992 Jul;66(1):119-27. doi: 10.1038/bjc.1992.227.
2
[Cardiotoxicity of 5-fluorouracil: a question of formulation].
Bull Cancer. 1994 Dec;81(12):1057-9.
3
The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate.
Br J Cancer. 1998;77(1):79-86. doi: 10.1038/bjc.1998.12.
4
The tris formulation of Fluorouracil is more cardiotoxic than the sodium-salt formulations.
Oncol Rep. 1994 Jan;1(1):173-4. doi: 10.3892/or.1.1.173.
5
Fluoroacetaldehyde as cardiotoxic impurity in fluorouracil (Roche).
Lancet. 1991 Mar 2;337(8740):560. doi: 10.1016/0140-6736(91)91353-v.
6
5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model.
Br J Cancer. 1997;76(9):1170-80. doi: 10.1038/bjc.1997.529.
7
31P-topical nuclear magnetic resonance (31P-TMR) studies of cardiotoxic effects of 5-fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR).
Jpn J Pharmacol. 1984 Apr;34(4):375-9. doi: 10.1254/jjp.34.375.
8
Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use.
J Pharm Biomed Anal. 2014 Sep;98:446-62. doi: 10.1016/j.jpba.2014.06.015. Epub 2014 Jun 19.
9
A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolism.
Cell Mol Biol (Noisy-le-grand). 1997 Jul;43(5):773-82.
10
Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Med Sci Monit. 2002 Jun;8(6):PI51-7.
引用本文的文献
1
Enzymatic carbon-fluorine bond cleavage by human gut microbes.
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2504122122. doi: 10.1073/pnas.2504122122. Epub 2025 Jun 13.
2
Dynamic observation of 5-fluorouracil-induced myocardial injury and mitochondrial autophagy in aging rats.
Exp Ther Med. 2021 Dec;22(6):1451. doi: 10.3892/etm.2021.10886. Epub 2021 Oct 14.
3
On Complex Formation between 5-Fluorouracil and β-Cyclodextrin in Solution and in the Solid State: IR Markers and Detection of Short-Lived Complexes by Diffusion NMR.
Molecules. 2020 Dec 3;25(23):5706. doi: 10.3390/molecules25235706.
4
Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.
Curr Oncol Rep. 2016 Jun;18(6):35. doi: 10.1007/s11912-016-0521-1.
5
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity.
BMC Pharmacol Toxicol. 2014 Sep 4;15:47. doi: 10.1186/2050-6511-15-47.
6
Capecitabine-induced cardiotoxicity: case report and review of the literature.
Curr Oncol. 2010 Feb;17(1):59-63. doi: 10.3747/co.v17i1.437.
7
Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracil.
Invest New Drugs. 2000 Nov;18(4):365-71. doi: 10.1023/a:1006401432488.
8
Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.
Drug Saf. 2000 Apr;22(4):263-302. doi: 10.2165/00002018-200022040-00002.
9
Cardiotoxicity of the antiproliferative compound fluorouracil.
Drugs. 1999 Apr;57(4):475-84. doi: 10.2165/00003495-199957040-00003.
10
Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.
Br J Cancer. 1998 Mar;77(6):973-7. doi: 10.1038/bjc.1998.160.
本文引用的文献
1
F Nuclear Magnetic Resonance Analysis of 5-Fluorouracil Metabolism in Four Differently Pigmented Strains of Nectria haematococca.
Appl Environ Microbiol. 1991 Dec;57(12):3605-12. doi: 10.1128/aem.57.12.3605-3612.1991.
2
Studies on fluorinated pyrimidines. IX. The degradation of 5-fluorouracil-6-C14.
J Biol Chem. 1960 Feb;235:433-7.
3
Cardiotoxic effects of 5-fluorouracil in the guinea pig.
Jpn J Pharmacol. 1980 Dec;30(6):871-9. doi: 10.1254/jjp.30.871.
4
Cardiac toxicity of 5-fluorouracil: a study on 1083 patients.
Tumori. 1982 Dec 31;68(6):505-10. doi: 10.1177/030089168206800609.
5
Base-catalyzed hydrolysis of 4-hydroperoxycyclophosphamide: evidence for iminocyclophosphamide as an intermediate.
J Med Chem. 1984 Apr;27(4):485-90. doi: 10.1021/jm00370a009.
6
NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
J Med Chem. 1984 Apr;27(4):466-85. doi: 10.1021/jm00370a008.
7
Fluorinated pyrimidines and their nucleosides.
Adv Enzymol Relat Areas Mol Biol. 1983;54:58-119.
8
Kinetics and mechanisms of hydrolysis of 5-halouracils.
J Org Chem. 1968 Sep;33(9):3460-8. doi: 10.1021/jo01273a022.
9
Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate.
Arch Neurol. 1970 Aug;23(2):155-60. doi: 10.1001/archneur.1970.00480260061008.
10
Rates of synthesis of ribosomal protein and total ribonucleic acid through the cell cycle of the fission yeast Schizosaccharomyces pombe.
Exp Cell Res. 1973 Oct;81(2):269-78. doi: 10.1016/0014-4827(73)90515-6.
Zotero 插件